2012
DOI: 10.1016/j.lfs.2012.10.003
|View full text |Cite
|
Sign up to set email alerts
|

Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson's disease mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
85
0
5

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 115 publications
(94 citation statements)
references
References 47 publications
4
85
0
5
Order By: Relevance
“…Previous studies in aged mice demonstrated that access to running wheels decreased microglia positive cells in the hippocampus (23,24). In addition, 4 wk of exercise training in a mice model of Parkinson's disease suppressed microglia activation in the substantia nigra pars compacta and striatum (40). Therefore, our data suggest that exercise training is able to inhibit microglia activation, which explains, at least in part, the autonomic adaptations in the trained SHR.…”
Section: Discussionsupporting
confidence: 65%
“…Previous studies in aged mice demonstrated that access to running wheels decreased microglia positive cells in the hippocampus (23,24). In addition, 4 wk of exercise training in a mice model of Parkinson's disease suppressed microglia activation in the substantia nigra pars compacta and striatum (40). Therefore, our data suggest that exercise training is able to inhibit microglia activation, which explains, at least in part, the autonomic adaptations in the trained SHR.…”
Section: Discussionsupporting
confidence: 65%
“…Many studies of similar chronic MPTPp regimens have described deficits in motor coordination as assessed by rotating rod performance (e.g., [2,9,13,44,45]), although some studies have not found significant alterations [46]. Some of those studies "pre-trained" the subjects prior to MPTPp treatment [44,45] and although baseline motor coordination assessments were performed in the current study, there was no required criterion or threshold for progression.…”
Section: Discussionmentioning
confidence: 89%
“…For example, when assessed within 48 h of the last MPTP treatment, male mice exhibit increased latencies in pole descent, decreased latencies to remain on a rotating rod, decreased locomotor activity, increased foot faults during beam crossing or grid tests, poor swimming ability, increased tail suspension immobility, increased akinesia and catalepsy, memory impairments in an avoidance task, and olfactory deficits [3,[6][7][8][9][10][11][12]. Similar treatment has also been described to cause long-lasting impairments (up to 6 months post-treatment) on latencies to remain on a rotating rod [2,13,14], in foot slips or gait alterations [15,16], on performance of the cued, but not spatial, version of a water maze task [16], and on baseline and amphetamine-induced locomotor activity [16].…”
Section: Introductionmentioning
confidence: 99%
“…CD11b is located on the plasma membrane of microglia, and CD11b expression is increased during the microglial activation [6]. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) has been used in animal models of Parkinson disease, and MPTP administration causes enhanced CD11b expression in the striatum and substantia nigra [7]. …”
Section: Introductionmentioning
confidence: 99%
“…Apoptosis maintains homeostasis; however, inappropriate or excessive apoptosis has been implicated in several types of neurodegenerative disorders, including ischemia [7,11,12]. Apoptosis after cerebral ischemia is one of the major pathways that lead to the process of cell death [13].…”
Section: Introductionmentioning
confidence: 99%